SENP7 Antibodies

Santa Cruz Biotechnology features a diverse variety of SENP7 monoclonal antibodies for advanced research in cellular biology. SENP7 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SENP7, or SUMO-specific protease 7, plays a critical role in the regulation of protein SUMOylation, a post-translational modification that influences numerous cellular processes such as gene expression, DNA repair, and cell cycle progression. By modulating the SUMOylation status of target proteins, SENP7 is essential for maintaining cellular homeostasis and responding to stress signals. SENP7 has emerged as a significant focus for research in cancer, neurodegenerative diseases, and other conditions due to its involvement in various signaling pathways. Researchers can explore SENP7's role in cellular functions through multiple experimental approaches, including protein localization studies and interaction analyses. Understanding SENP7's regulatory mechanisms can provide valuable insights into disease development and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of SENP7's role in health and disease.